Danaher Corporation (DHR)
Danaher Corporation (DHR) carries a ŷRobot AI score of 64 out of 100. The model's fair value estimate is $235.06, 2.6% above the last close of $229.04. The chart signal reads Sell.
| Metric | DHR |
|---|---|
| AI score | 64 / 100 |
| Chart signal | Sell |
| Fair value estimate | $235.06 |
| Upside to fair value | 2.6% |
| Previous close | $229.04 |
| P/E | 39.51 |
| Price / sales | 5.93 |
| Market cap | $157.95B |
| EPS | 5.36 |
| Revenue growth | -2.5% |
| 1-year price change | 3.8% |
How these numbers are built: the AI score, the fair value model, and the chart signal.
Other Healthcare stocks: Eli Lilly and Company, Johnson & Johnson, AbbVie Inc, UnitedHealth Group Incorporated, Merck & Company Inc, Novartis AG ADR.
Questions about DHR
Is DHR overvalued or undervalued right now?
As of Oct 16, 2026, ŷRobot's fair-value model estimates Danaher Corporation (DHR) at $235.06 against a last close of $229.04, implying 2.6% upside to the model's estimate.
Is DHR's chart signal bullish or bearish?
The chart-signal model classifies DHR as Neutral as of Oct 16, 2026, with a signal score of -0.15 on a -1 to 1 scale.
What is DHR's ŷRobot AI score?
DHR scores 64 out of 100 on ŷRobot's AI composite, which measures how strongly the fair-value and chart models agree, as of Oct 16, 2026.
Is DHR stock expensive on P/E and P/S?
DHR trades at 39.5 times earnings and 5.9 times sales as of Oct 16, 2026.
What does DHR's seasonal forecast show?
ŷRobot's seasonal forecast curve for DHR reads -0.4% at 30 days, +1.3% at 90 days, and +3.8% at one year as of Oct 16, 2026. Seasonal tendencies are historical patterns, not predictions.
How fast is DHR growing?
Danaher Corporation's revenue growth is -2.5% and free-cash-flow growth is -0.1% on the latest reported figures.
DHR chart and technical read · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.